Skip to main content
. Author manuscript; available in PMC: 2024 Nov 7.
Published in final edited form as: Cancer Cytopathol. 2020 Aug 18;129(2):104–113. doi: 10.1002/cncy.22338

Figure 6.

Figure 6.

(A) Fine-needle aspiration of a secretory carcinoma is shown. By immunohistochemistry, secretory carcinoma cells are (B) negative for nuclear receptor subfamily 4 group A member 3 (NR4A3) and (C) negative for DOG1. (D) By fluorescence in situ hybridization, the tumor cells are negative for NR4A3 rearrangement, showing a lack of break-apart signal (H&E stain; original magnification ×200 in A-C, ×400 in D).